{"id":57457,"date":"2025-09-19T13:46:58","date_gmt":"2025-09-19T13:46:58","guid":{"rendered":"https:\/\/ibima.eu\/?p=57457"},"modified":"2025-11-25T09:46:28","modified_gmt":"2025-11-25T09:46:28","slug":"ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy","status":"publish","type":"post","link":"https:\/\/ibima.eu\/en\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/","title":{"rendered":"IBIMA acoge la formaci\u00f3n \u00abArtificial Intelligence in Cardiovascular Pharmacotherapy\u00bb"},"content":{"rendered":"\n[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbsection\u00bb _builder_version=\u00bb4.27.4″ custom_margin=\u00bb2px|||||\u00bb custom_padding=\u00bb5px|||||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb4.27.4″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb44px|auto|40px|auto|false|false\u00bb custom_padding=\u00bb|||30px||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.16″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.27.4″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb custom_margin=\u00bb-36px|||||\u00bb global_colors_info=\u00bb{}\u00bb]
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

IBIMA Plataforma BIONAND ha celebrado en la ma\u00f1ana del mi\u00e9rcoles, 10 de septiembre de 2025, la sesi\u00f3n formativa Artificial Intelligence in Cardiovascular Pharmacotherapy<\/em>, una iniciativa que refuerza la importancia del proyecto europeo ORACLE liderado por el Dr. Francesco Costa. El encuentro, desarrollado en formato h\u00edbrido y de forma presencial en el Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga y Plataforma en Nanomedicina, ha despertado un notable inter\u00e9s entre profesionales e investigadores.<\/p>\n

Durante la jornada, la Dra. Arancha D\u00edaz y el Dr. Francesco Costa han compartido los avances m\u00e1s recientes sobre c\u00f3mo la inteligencia artificial est\u00e1 revolucionando la farmacoterapia cardiovascular, ofreciendo nuevas herramientas para la investigaci\u00f3n biom\u00e9dica y la pr\u00e1ctica cl\u00ednica.<\/p>\n

Cabe destacar que la formaci\u00f3n ha reunido a participantes tanto presenciales como online, consolidando el compromiso de IBIMA Plataforma BIONAND con la transferencia de conocimiento y la innovaci\u00f3n en salud. \u201cLa inteligencia artificial est\u00e1 abriendo una nueva era en la farmacoterapia cardiovascular. Nos permite analizar datos complejos de manera m\u00e1s r\u00e1pida y precisa, optimizar tratamientos y acercar la investigaci\u00f3n a la pr\u00e1ctica cl\u00ednica. Con iniciativas como ORACLE buscamos que esta innovaci\u00f3n tenga un impacto real en la salud de los pacientes\u201d, ha destacado el Dr. Francesco Costa, investigador principal del proyecto.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3″ disabled_on=\u00bboff|off|off\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb width=\u00bb75%\u00bb custom_padding=\u00bb||||false|true\u00bb global_colors_info=\u00bb{}\u00bb locked=\u00bboff\u00bb][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||||true|true\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″][dsm_perspective_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/20250910-Fcosta-IA-Cardiaco-4.jpeg\u00bb title_text=\u00bb20250910 – Fcosta IA Card\u00edaco (4)\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/internacional\/proyectos-internacionales\/\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb15px|15px|15px|15px|true|true\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb border_color_all=\u00bb#0C71C3″ sticky_enabled=\u00bb0″ max_height=\u00bb1000px\u00bb height=\u00bb100px\u00bb width=\u00bb100%\u00bb][\/dsm_perspective_image][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||||true|true\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb global_colors_info=\u00bb{}\u00bb][dsm_perspective_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/20250910-Fcosta-IA-Cardiaco-2.jpeg\u00bb title_text=\u00bb20250910 – Fcosta IA Card\u00edaco (2)\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/internacional\/redes-de-cooperacion-internacional-2\/\u00bb disabled_on=\u00bboff|off|off\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb15px|15px|15px|15px|true|true\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″][\/dsm_perspective_image][\/et_pb_column][et_pb_column type=\u00bb1_3″ _builder_version=\u00bb4.25.0″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||||true|true\u00bb animation_style=\u00bbslide\u00bb animation_direction=\u00bbbottom\u00bb global_colors_info=\u00bb{}\u00bb][dsm_perspective_image src=\u00bbhttps:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/20250910-Fcosta-IA-Cardiaco-1.jpeg\u00bb title_text=\u00bb20250910 – Fcosta IA Card\u00edaco (1)\u00bb url=\u00bbhttps:\/\/ibima.eu\/es\/internacional\/recursos-humanos-internacional\/\u00bb _builder_version=\u00bb4.27.4″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb15px|15px|15px|15px|true|true\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″][\/dsm_perspective_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"

IBIMA Plataforma BIONAND ha celebrado en la ma\u00f1ana del mi\u00e9rcoles, 10 de septiembre de 2025, la sesi\u00f3n formativa Artificial Intelligence in Cardiovascular Pharmacotherapy, una iniciativa que refuerza la importancia del proyecto europeo ORACLE liderado por el Dr. Francesco Costa. El encuentro, desarrollado en formato h\u00edbrido y de forma presencial en el Instituto de Investigaci\u00f3n Biom\u00e9dica […]<\/p>\n","protected":false},"author":4,"featured_media":57478,"comment_status":"open","ping_status":"closed","sticky":false,"template":"noticias","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"\n

IBIMA Plataforma BIONAND y Plataforma en Nanomedicina se sit\u00faa como uno de los l\u00edderes en el \u00e1mbito nacional en Investigaci\u00f3n Biom\u00e9dica<\/em><\/h2>\n\n\n\n

El Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND) se consolida como uno de los l\u00edderes en el \u00e1mbito nacional en investigaci\u00f3n en salud. M\u00e1laga, por tanto, encabeza las investigaciones biom\u00e9dicas en Espa\u00f1a con el fin de resolver problemas de salud y en el que trabajan 1500 investigadores con dilatada experiencia.<\/p>\n\n\n\n

Al cierre de 2023, IBIMA Plataforma BIONAND ha obtenido una suma total de 30 millones de euros<\/strong> en fondos captados para la investigaci\u00f3n en salud debido a las actividades estrat\u00e9gicas llevadas a cabo durante el a\u00f1o natural. Esto se traduce en un aumento de 6 millones de euros m\u00e1s respecto al a\u00f1o 2022.<\/p>\n\n\n\n

Destaca la concesi\u00f3n de 2,5 millones de euros<\/strong> del Programa FORTALECE. Este proyecto incrementar\u00e1 la actividad de I+D+i y facilitar\u00e1 la transferencia de los resultados logrados a la sociedad en forma de avances en el conocimiento, prevenci\u00f3n, diagn\u00f3stico y tratamiento de las enfermedades en patolog\u00edas relevantes (enfermedades cr\u00f3nicas, cardiovasculares, neurol\u00f3gicas y c\u00e1ncer). Adem\u00e1s, permitir\u00e1 el desarrollo de ciencia de frontera liderada por los seis grupos que lo integran: dos grupos del Hospital Universitario Virgen de la Victoria cuyos investigadores responsables son Francisco J. Tinahones y Ra\u00fal J. Andrade, dos grupos del Hospital Regional Universitario de M\u00e1laga encabezados por Mar\u00eda Jos\u00e9 Torres y por Antonia Mar\u00eda Serrano, y dos grupos de la Universidad de M\u00e1laga liderados por Jos\u00e9 Manuel Jim\u00e9nez y por Melissa Garc\u00eda.<\/p>\n\n\n\n

IBIMA Plataforma BIONAND tambi\u00e9n ha obtenido 900.000 euros <\/strong>por la concesi\u00f3n de las tres plataformas del Instituto de Salud Carlos III (Innovaci\u00f3n, Ensayos Cl\u00ednicos y Biobanco), as\u00ed como el programa CERTERA con un total de 400.000 euros<\/strong>, y los ensayos cl\u00ednicos independientes con valor de 800.000 euros<\/strong>. Tambi\u00e9n, entre los grandes proyectos, destacan tres en colaboraci\u00f3n p\u00fablico-privada, que re\u00fanen una financiaci\u00f3n conjunta de 3 millones de euros.<\/p>\n\n\n\n

Cabe destacar el posicionamiento de IBIMA Plataforma BIONAND <\/a>en el \u00e1mbito internacional, situ\u00e1ndose a la vanguardia de la investigaci\u00f3n biom\u00e9dica de excelencia en Europa. En 2023, este reconocimiento queda avalado con la concesi\u00f3n de uno de los apoyos de mayor reconocimiento cient\u00edfico internacional, ERC Starting. Con un presupuesto de m\u00e1s de 1,4 millones de euros, este Instituto se enfrenta a un gran desaf\u00edo cient\u00edfico en la prevenci\u00f3n y predicci\u00f3n del infarto de miocardio, que supondr\u00e1 un gran avance en la frontera del conocimiento, generando un importante impacto cient\u00edfico con traslaci\u00f3n cl\u00ednica. Adicionalmente, cabe resaltar\u00a0 la atracci\u00f3n de talento internacional con la concesi\u00f3n del Marie Slowdoska Curie en el \u00e1rea de alergia, tres proyectos financiados en el marco del programa EU4Health y otros tres dentro del cl\u00faster salud de Horizonte Europa en colaboraci\u00f3n con la European Clinical Research Infrastructure Network (ECRIN).<\/a> IBIMA Plataforma BIONAND cierra este 2023 con tres nuevos proyectos en resoluci\u00f3n provisional de las convocatorias SUDOE, ERA4Health y EU4Health, que generar\u00e1 nuevas colaboraciones y resultados con impacto internacional.<\/p>\n\n\n\n

En este a\u00f1o que finaliza ha sido muy significativo el incremento de ensayos cl\u00ednicos desarrollados en el Instituto. Actualmente el centro participa en 325 ensayos cl\u00ednicos, lo que supone un incremento del 24% respecto al a\u00f1o 2022<\/strong>.<\/p>\n\n\n\n

Asimismo, parte del \u00e9xito de IBIMA Plataforma BIONAND reside en la aportaci\u00f3n activa de la participaci\u00f3n ciudadana. Eventos como el I Torneo de F\u00fatbol 7 HRUM\/IBIMA o la I Carrera Solidaria Contra la Obesidad han sido parte de las acciones llevadas a cabo y donde se han recaudado alrededor de 30.000 euros para fomentar la investigaci\u00f3n biom\u00e9dica.<\/p>\n\n\n\n

Especial importancia para el crecimiento del Instituto ha tenido el acto solidario de Francisco Jes\u00fas Sarmiento, que ha donado, en concepto de herencia, un total de 230.000 euros<\/strong> para el desarrollo de distintas l\u00edneas de investigaci\u00f3n en el Instituto.<\/p>\n\n\n\n

\u201cM\u00e1laga cuenta con un centro de excelencia en Investigaci\u00f3n Biom\u00e9dica. Es IBIMA Plataforma BIONAND, que, en estos \u00faltimos a\u00f1os, ha tenido un crecimiento sostenido en la captaci\u00f3n de recursos, acerc\u00e1ndonos este a\u00f1o a los 30 millones de euros<\/strong>. Esto supone que IBIMA Plataforma BIONAND se posicione como uno de los Institutos de Investigaci\u00f3n Biom\u00e9dica m\u00e1s relevante de nuestro pa\u00eds\u201d, ha se\u00f1alado Francisco J. Tinahones, director cient\u00edfico del Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga y Plataforma en Nanomedicina.<\/p>\n","_et_gb_content_width":"","footnotes":""},"categories":[2239,2226],"tags":[2229,2231,2232,2227,2230,2228],"class_list":["post-57457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-oracle","category-oraclenews","tag-erc","tag-excelencia","tag-horizonte-europa","tag-infarto","tag-investigacion","tag-miocardio"],"acf":[],"yoast_head":"\nIBIMA acoge la formaci\u00f3n "Artificial Intelligence in Cardiovascular Pharmacotherapy" - Ibima<\/title>\n<meta name=\"description\" content=\"IBIMA acoge la formaci\u00f3n "Artificial Intelligence in Cardiovascular Pharmacotherapy" de la mano del Dr. Francesco Costa\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibima.eu\/en\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IBIMA acoge la formaci\u00f3n "Artificial Intelligence in Cardiovascular Pharmacotherapy" - Ibima\" \/>\n<meta property=\"og:description\" content=\"IBIMA acoge la formaci\u00f3n "Artificial Intelligence in Cardiovascular Pharmacotherapy" de la mano del Dr. Francesco Costa\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibima.eu\/en\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"Ibima\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T13:46:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-25T09:46:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/202509-Formacion-Oracle-FCosta.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Divulgaci\u00f3n\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divulgaci\u00f3n\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/\"},\"author\":{\"name\":\"Divulgaci\u00f3n\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/31b8becdcc53729d5a51d5b3436ce9a5\"},\"headline\":\"IBIMA acoge la formaci\u00f3n \u00abArtificial Intelligence in Cardiovascular Pharmacotherapy\u00bb\",\"datePublished\":\"2025-09-19T13:46:58+00:00\",\"dateModified\":\"2025-11-25T09:46:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/\"},\"wordCount\":600,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/202509-Formacion-Oracle-FCosta.jpeg\",\"keywords\":[\"ERC\",\"Excelencia\",\"Horizonte Europa\",\"infarto\",\"Investigacion\",\"miocardio\"],\"articleSection\":[\"Noticias ORACLE\",\"Noticias Oracle\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/\",\"url\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/\",\"name\":\"IBIMA acoge la formaci\u00f3n \\\"Artificial Intelligence in Cardiovascular Pharmacotherapy\\\" - Ibima\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/202509-Formacion-Oracle-FCosta.jpeg\",\"datePublished\":\"2025-09-19T13:46:58+00:00\",\"dateModified\":\"2025-11-25T09:46:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/31b8becdcc53729d5a51d5b3436ce9a5\"},\"description\":\"IBIMA acoge la formaci\u00f3n \\\"Artificial Intelligence in Cardiovascular Pharmacotherapy\\\" de la mano del Dr. Francesco Costa\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/202509-Formacion-Oracle-FCosta.jpeg\",\"contentUrl\":\"https:\\\/\\\/ibima.eu\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/202509-Formacion-Oracle-FCosta.jpeg\",\"width\":1600,\"height\":1200,\"caption\":\"202509 - Formaci\u00f3n Oracle FCosta\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IBIMA acoge la formaci\u00f3n \u00abArtificial Intelligence in Cardiovascular Pharmacotherapy\u00bb\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ibima.eu\\\/es\\\/\",\"name\":\"Ibima\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibima.eu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibima.eu\\\/es\\\/#\\\/schema\\\/person\\\/31b8becdcc53729d5a51d5b3436ce9a5\",\"name\":\"Divulgaci\u00f3n\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g\",\"caption\":\"Divulgaci\u00f3n\"},\"url\":\"https:\\\/\\\/ibima.eu\\\/en\\\/author\\\/divulgacioncientifica\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IBIMA acoge la formaci\u00f3n \"Artificial Intelligence in Cardiovascular Pharmacotherapy\" - Ibima","description":"IBIMA acoge la formaci\u00f3n \"Artificial Intelligence in Cardiovascular Pharmacotherapy\" de la mano del Dr. Francesco Costa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibima.eu\/en\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/","og_locale":"en_GB","og_type":"article","og_title":"IBIMA acoge la formaci\u00f3n \"Artificial Intelligence in Cardiovascular Pharmacotherapy\" - Ibima","og_description":"IBIMA acoge la formaci\u00f3n \"Artificial Intelligence in Cardiovascular Pharmacotherapy\" de la mano del Dr. Francesco Costa","og_url":"https:\/\/ibima.eu\/en\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/","og_site_name":"Ibima","article_published_time":"2025-09-19T13:46:58+00:00","article_modified_time":"2025-11-25T09:46:28+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/202509-Formacion-Oracle-FCosta.jpeg","type":"image\/jpeg"}],"author":"Divulgaci\u00f3n","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Divulgaci\u00f3n","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#article","isPartOf":{"@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/"},"author":{"name":"Divulgaci\u00f3n","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/31b8becdcc53729d5a51d5b3436ce9a5"},"headline":"IBIMA acoge la formaci\u00f3n \u00abArtificial Intelligence in Cardiovascular Pharmacotherapy\u00bb","datePublished":"2025-09-19T13:46:58+00:00","dateModified":"2025-11-25T09:46:28+00:00","mainEntityOfPage":{"@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/"},"wordCount":600,"commentCount":0,"image":{"@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/202509-Formacion-Oracle-FCosta.jpeg","keywords":["ERC","Excelencia","Horizonte Europa","infarto","Investigacion","miocardio"],"articleSection":["Noticias ORACLE","Noticias Oracle"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/","url":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/","name":"IBIMA acoge la formaci\u00f3n \"Artificial Intelligence in Cardiovascular Pharmacotherapy\" - Ibima","isPartOf":{"@id":"https:\/\/ibima.eu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#primaryimage"},"image":{"@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/202509-Formacion-Oracle-FCosta.jpeg","datePublished":"2025-09-19T13:46:58+00:00","dateModified":"2025-11-25T09:46:28+00:00","author":{"@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/31b8becdcc53729d5a51d5b3436ce9a5"},"description":"IBIMA acoge la formaci\u00f3n \"Artificial Intelligence in Cardiovascular Pharmacotherapy\" de la mano del Dr. Francesco Costa","breadcrumb":{"@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#primaryimage","url":"https:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/202509-Formacion-Oracle-FCosta.jpeg","contentUrl":"https:\/\/ibima.eu\/wp-content\/uploads\/2025\/09\/202509-Formacion-Oracle-FCosta.jpeg","width":1600,"height":1200,"caption":"202509 - Formaci\u00f3n Oracle FCosta"},{"@type":"BreadcrumbList","@id":"https:\/\/ibima.eu\/ibima-acoge-la-formacion-artificial-intelligence-in-cardiovascular-pharmacotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/ibima.eu\/es\/"},{"@type":"ListItem","position":2,"name":"IBIMA acoge la formaci\u00f3n \u00abArtificial Intelligence in Cardiovascular Pharmacotherapy\u00bb"}]},{"@type":"WebSite","@id":"https:\/\/ibima.eu\/es\/#website","url":"https:\/\/ibima.eu\/es\/","name":"Ibima","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibima.eu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/ibima.eu\/es\/#\/schema\/person\/31b8becdcc53729d5a51d5b3436ce9a5","name":"Divulgaci\u00f3n","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a96ea83ae1abdc712e138b425847bdc88b61da083b2e05603d5a5305a98cd781?s=96&d=mm&r=g","caption":"Divulgaci\u00f3n"},"url":"https:\/\/ibima.eu\/en\/author\/divulgacioncientifica\/"}]}},"_links":{"self":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/57457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/comments?post=57457"}],"version-history":[{"count":9,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/57457\/revisions"}],"predecessor-version":[{"id":57697,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/posts\/57457\/revisions\/57697"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media\/57478"}],"wp:attachment":[{"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/media?parent=57457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/categories?post=57457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibima.eu\/en\/wp-json\/wp\/v2\/tags?post=57457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}